• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Regional Heterogeneity in the Risk of Thrombosis and Bleeding in Patients With Peripheral Artery Disease.

作者信息

Goto Shinya, Yamasawa Daisuke, Goto Shinichi

机构信息

Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan.

Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan.

出版信息

JACC Asia. 2025 May 7;5(6):755-7. doi: 10.1016/j.jacasi.2025.03.007.

DOI:10.1016/j.jacasi.2025.03.007
PMID:40396938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12287732/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbe/12287732/78b97aaffa00/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbe/12287732/c2a4fad77b52/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbe/12287732/78b97aaffa00/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbe/12287732/c2a4fad77b52/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbe/12287732/78b97aaffa00/gr1.jpg

相似文献

1
Regional Heterogeneity in the Risk of Thrombosis and Bleeding in Patients With Peripheral Artery Disease.外周动脉疾病患者血栓形成和出血风险的区域异质性。
JACC Asia. 2025 May 7;5(6):755-7. doi: 10.1016/j.jacasi.2025.03.007.
2
Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization.不同剂量普通肝素对接受心导管插入术儿童预防动脉血栓形成的作用
Cochrane Database Syst Rev. 2014 Mar 4(3):CD010196. doi: 10.1002/14651858.CD010196.pub2.
3
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.用于预防外周动脉搭桥术后血栓形成的抗血小板药物。
Cochrane Database Syst Rev. 2015 Feb 19;2015(2):CD000535. doi: 10.1002/14651858.CD000535.pub3.
4
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.氯吡格雷和双嘧达莫缓释制剂预防闭塞性血管事件（技术评估 90 号回顾）：系统评价和经济分析。
Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310.
5
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备：证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
6
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.抗血小板和抗凝药物用于抗磷脂抗体个体血栓形成的一级预防。
Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2.
7
A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease.阿司匹林单药治疗与其他抗血小板治疗方案在周围动脉疾病中的疗效的系统评价。
J Vasc Surg. 2018 Jun;67(6):1922-1932.e6. doi: 10.1016/j.jvs.2018.02.047.
8
Ultrasound-guided versus anatomic landmark-guided percutaneous femoral artery access.超声引导与解剖标志引导下经皮股动脉穿刺入路
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD014594. doi: 10.1002/14651858.CD014594.pub2.
9
Infusion techniques for peripheral arterial thrombolysis.外周动脉溶栓的输注技术。
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD000985. doi: 10.1002/14651858.CD000985.pub3.
10
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.

本文引用的文献

1
Validation of High Ischemic and Bleeding Risk Criteria of European Guidelines in Peripheral Arterial Disease.欧洲外周动脉疾病指南中高缺血和出血风险标准的验证
JACC Asia. 2025 Jun;5(6):744-754. doi: 10.1016/j.jacasi.2025.01.018. Epub 2025 Apr 15.
2
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF.亚洲和非亚洲国家患者的房颤结局：来自GARFIELD-AF研究的见解
Open Heart. 2025 Feb 6;12(1):e003109. doi: 10.1136/openhrt-2024-003109.
3
Asian perspective on the recently published practice guideline for acute coronary syndrome by ESC.
亚洲对欧洲心脏病学会近期发布的急性冠状动脉综合征实践指南的看法。
Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):162-164. doi: 10.1093/ehjacc/zuad126.
4
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.《东亚急性冠状动脉综合征患者或接受经皮冠状动脉介入治疗患者抗血小板治疗专家共识声明（2018年更新版）》
Sci Bull (Beijing). 2019 Feb 15;64(3):166-179. doi: 10.1016/j.scib.2018.12.020. Epub 2018 Dec 28.
5
Potent antithrombotic treatments in Asian vs. non-Asian patients.亚洲患者与非亚洲患者的强效抗血栓治疗
Eur Heart J. 2022 Oct 7;43(37):3553-3555. doi: 10.1093/eurheartj/ehac390.
6
Global Trial or Local One?全球试验还是局部试验？
Circulation. 2019 Dec 3;140(23):1878-1880. doi: 10.1161/CIRCULATIONAHA.119.043629. Epub 2019 Sep 25.
7
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.稳定型冠状动脉疾病患者的心绞痛与未来心血管事件：来自降低动脉粥样硬化血栓形成以持续健康（REACH）注册研究的见解
J Am Heart Assoc. 2016 Sep 28;5(10):e004080. doi: 10.1161/JAHA.116.004080.
8
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.亚洲地区心房颤动患者中阿哌沙班预防卒中的疗效和安全性：阿哌沙班减少心房颤动血栓栓塞事件（ARISTOTLE）试验的亚分析。
Am Heart J. 2014 Sep;168(3):303-9. doi: 10.1016/j.ahj.2014.06.005. Epub 2014 Jun 6.
9
Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.专家共识文件：世界心脏联合会专家共识声明：抗血小板治疗在东亚 ACS 或 PCI 患者中的应用。
Nat Rev Cardiol. 2014 Oct;11(10):597-606. doi: 10.1038/nrcardio.2014.104. Epub 2014 Aug 26.
10
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.2000 年和 2010 年全球外周动脉疾病患病率和危险因素的估计值比较：系统评价和分析。
Lancet. 2013 Oct 19;382(9901):1329-40. doi: 10.1016/S0140-6736(13)61249-0. Epub 2013 Aug 1.